Taking steps now to enhance surveillance, accelerate vaccine testing and development, and improve the security of farms, will help prevent H5N1 from becoming the next pandemic. It is not too late to tackle this threat, but it is ultimately up to us to take action.
This report summarizes discussions held during a workshop hosted by the Council on Strategic Risks on September 26, 2022, focused on ending extreme risks from biological threats. Conversations centered around a few core subject areas: pathogen early warning, public-private collaboration, interagency efforts and collaboration, and strategic communications.
CSR is announcing a call for applications for the 2023–2024 class of our Fellowship for Ending Bioweapons.
NSABB's recommendations cover research involving enhanced pandemic potential pathogens, as well as dual-use research of concern.
The Council on Strategic Risks seeks to hire a full-time team member focused on addressing biological threats. This may be a Fellow or Senior Fellow role, depending on the expertise of the applicants.
DoD's major update for its Chemical and Biological Defense Program outlines a new, two-phased approach to medical countermeasures implementation. But
In this report, a team of experts assess the current state of domestic and global pathogen early warning systems and lay out important steps for improving capabilities.
As presented by Dr. Yong-Bee Lim in Geneva, 29 November 2022.
Ambassador Ahmet Üzümcü, presented the case for The International Biotech Organization (IBTO) to the Biological Sub-Working Group of the Global Partnership Against the Spread of Weapons and Materials of Mass Destruction on October 6, 2022.
Nolan Center experts examine the Biden Administration's new National Biodefense Strategy and Implementation Plan and its accompanying National Security Memorandum.
